The early treatment of Parkinson's disease: levodopa, dopamine agonists or both

This publication has 57 references indexed in Scilit:

• Does Levodopa Accelerate Parkinson??s Disease?
  Drugs & Aging, 1999
• Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
• A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine
  Movement Disorders, 1995
• A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
  Journal of Neurology, Neurosurgery & Psychiatry, 1994
• Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study
  Movement Disorders, 1994
• Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
  BMJ, 1993
• Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 rats
  Neurobiology of Aging, 1992
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture
  Journal of Neuroscience Research, 1990
• Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part I
  Annals of Neurology, 1988
• Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture
  Life Sciences, 1981